Studies on the synthesis and activity of three tripalladium complexes containing planaramine ligands

ChemMedChem

Volumn 4, Issue 11, 2009, Pages 1841-1849

  Farhad, Mohammad ^a   Yu, Jun Qing ^a   Beale, Philip ^a   Fisher, Keith ^b   Huq, Fazlul ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Antitumor agents; Bioinorganic chemistry; Ovarian cancer; Palladium; Platinum

Indexed keywords

2 HYDROXYPYRIDINE; 3 HYDROXYPYRIDINE; 4 HYDROXYPYRIDINE; ANTINEOPLASTIC AGENT; CISPLATIN; MH3; MH4; MH5; PALLADIUM; PLATINUM DERIVATIVE; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXICITY; DNA BINDING; DNA CONFORMATION; DNA STRAND; DRUG BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HYDROGEN BOND; PRIORITY JOURNAL;

CELL LINE, TUMOR; CISPLATIN; DNA; DNA ADDUCTS; HUMANS; HYDROGEN BONDING; LIGANDS; ORGANOMETALLIC COMPOUNDS; PALLADIUM; PLASMIDS;

EID: 73449092195     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.200900267     Document Type: Article

References (26)

1. F. Huq, H. Tayyem, A. Abdullah, P. Beale, J. Inorg. Biochem. 2007, 101, 30-35.
2. F. Huq, M. Farhad, A. Abdullah, P. Beale, Asian J. Chem. 2006, 18, 1607-1625.
3. F. Huq, H. Daghriri, J. Q. Yu, P. Beale, K. Fisher, Int. J. Pure Appl. Chem. 2006, 1, 493-507.
4. H. Daghriri, F. Huq, P. Beale, J. Inorg. Biochem. 2004, 98, 1722-1733.
5. H. Cheng, F. Huq, P. Beale, K. Fisher, Eur. J. Med. Chem. 2006, 41, 896-903.
6. H. Tayyem, F. Huq, J. Q. Yu, P. Beale, K. Fisher, ChemMedChem 2008, 3, 145-151.
7. D. Wang, S. J. Lippard, Nat. Rev. Drug Discovery 2005, 4, 307-320.
8. P. A. Andrews, S. Velury, S. C. Mann, S. B. Howell, Cancer Res. 1988, 48, 68-73.
9. P. Di Blasi, A. Bernareggi, G. Beggiolin, L. Piazzoni, E. Menta, M. L. Formento, Anticancer Res. 1998, 18, 3113-3117.
10. N. Farrell in Platinum-based drugs in cancer therapy (Eds.: L. R. Kelland, N. Farrell, N. J.Totowa), Humana Press, 2000, pp. 321-338.
11. F. Huq, M. Farhad, J. Q. Yu, P. Beale, K. Fisher, unpublished results.
12. N. J. Wheate, J. G. Collins, Curr. Med. Chem. Anti Cancer Agents 2005, 5, 267-269.
13. A. Ghezzi, M. Aceto, C. Cassino, E. Gabano, D. J. Osella, Inorg. Biochem. 2004, 98, 73-78.
14. Q. Liu, Y. Qu, R. VanAntwerpen, N. Farrell, Biochemistry 2006, 45, 4248-4256.
15. Y. P. Ho, S. C. Au-Yeung, K. K. To, Med. Res. Rev. 2003, 23, 633-655.
16. N. Summa, J. Maigut, R. Puchta, R. van Eldik, Inorg. Chem. 2007, 46, 2094-2104.
17. H. Cheng, F. Huq, P. Beale, K. Fisher, Euro. J. Med. Chem. 2005, 40, 772-781.
18. Z. H. Siddik, Oncogene 2003, 22, 7265-7279.
19. P. W. Atkins, Physical chemistry, Oxford University Press, Oxford, 1998.
20. N. Stellwagen, DNA gel electrophoresis. Nucleic acid electrophoresis, Springer, Berlin, New York, 1998.
21. G. B. Onoa, V. Moreno, Int. J. Pharm. 2002, 245, 55-65.
22. L. A. Smith, J. G. Chirikjian, Biol. Chem. 1979, 254, 1003-1006.
23. R. I. Freshney, Culture of animal cells : a manual of basic technique, Wiley, New York, 2000.
24. T. J. Mosmann, Immunol. Methods 1983, 65, 55-63.
25. D. D. Bowtell, Anal. Biochem. 1987, 162, 463-465.
26. J. Holford, P. J. Beale, F. E. Boxall, S. Y. Sharp, L. R. Kelland, Eur. J. Cancer 2000, 36, 1984-1990.